Post-ASCO & Post- ESMO 2024 Virtual Oncology Review
Starts On:
10/07/2024: 8:00 AM
Ends On:
01/31/2025: 11:45 PM
Type:
Online Course
Credits:
4
Description:
Watch Videos
Atlantic Health System is accredited by the Medical Society of New Jersey to provide continuing medical education credits for physicians.
Atlantic Health System designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All individuals in control of content report no relevant financial relationship.
Allyson Ocean, MD
Michael A. Postow, MD
Breast Cancer - Heather McArthur, MD, MPH
Lung Cancer - Hossein Borghaei, DO, MS
These videos:
Were originally recorded on September 21, 2024
Were reviewed on September 21, 2024
Will expire on January 31, 2025
Atlantic Health System is accredited by the Medical Society of New Jersey to provide continuing medical education credits for physicians.
Atlantic Health System designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All individuals in control of content report no relevant financial relationship.
Allyson Ocean, MD
Michael A. Postow, MD
Breast Cancer - Heather McArthur, MD, MPH
Lung Cancer - Hossein Borghaei, DO, MS
These videos:
Were originally recorded on September 21, 2024
Were reviewed on September 21, 2024
Will expire on January 31, 2025
Objectives:
After participation, the learner should be able to:
Review latest advances in cancer research presented at the ASCO Annual Meeting
Review latest advances in cancer research presented at the ESMO Annual Meeting
Describe the optimal roles of novel diagnostics and treatments for patients with cancer
Review latest advances in cancer research presented at the ASCO Annual Meeting
Review latest advances in cancer research presented at the ESMO Annual Meeting
Describe the optimal roles of novel diagnostics and treatments for patients with cancer